PHLI — PacificHealth Laboratories Income Statement

0.000.00%

Last trade - 00:00

Consumer DefensivesHighly SpeculativeMicro Cap

Annual income statement for PacificHealth Laboratories, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	C2007 December 31st	2008 December 31st	2009 December 31st	2010 December 31st	2011 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	7.43	7.24	8	7.2	6.91
Cost of Revenue
Gross Profit	2.98	3.23	3.71	3.16	2.99
Selling / General / Administrative Expenses
Research And Development
Unusual Expense / Income
Total Operating Expenses	8.79	9.28	9.94	7.96	7.39
Operating Profit	-1.36	-2.04	-1.94	-0.76	-0.474
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-1.28	-1.99	-1.94	-0.761	-0.486
Provision for Income Taxes
Net Income After Taxes	-1.28	-1.99	-1.68	-0.761	-0.486
Net Income Before Extraordinary Items
Net Income	-1.28	-1.99	-1.68	-0.761	-0.486
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income	-1.28	-1.99	-1.68	-0.761	-0.486
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-0.063	-0.097	-0.087	-0.047	-0.025
Dividends per Share